NKTX
Price:
$3.19
Market Cap:
$225.08M
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on t...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
NASDAQ
Ticker
NKTX
According to Nkarta, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 190.26M. This represents a change of -40.60% compared to the average of 320.29M of the last 4 quarters.
The mean historical Enterprise Value of Nkarta, Inc. over the last ten years is 647.26M. The current 190.26M Enterprise Value has changed 2.84% with respect to the historical average. Over the past ten years (40 quarters), NKTX's Enterprise Value was at its highest in in the December 2020 quarter at 1.92B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
647.26M
Median
418.39M
Minimum
245.64M
Maximum
1.54B
Discovering the peaks and valleys of Nkarta, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 528.88%
Maximum Annual Enterprise Value = 1.54B
Minimum Annual Increase = -51.76%
Minimum Annual Enterprise Value = 245.64M
Year | Enterprise Value | Change |
---|---|---|
2023 | 380.79M | 22.42% |
2022 | 311.04M | -31.79% |
2021 | 456.00M | -51.76% |
2020 | 945.31M | -38.81% |
2019 | 1.54B | 528.88% |
The current Enterprise Value of Nkarta, Inc. (NKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
382.61M
5-year avg
727.58M
10-year avg
647.26M
Nkarta, Inc.’s Enterprise Value is less than Monte Rosa Therapeutics, Inc. (481.73M), less than Lyell Immunopharma, Inc. (213.52M), less than Generation Bio Co. (212.96M), less than Sana Biotechnology, Inc. (773.99M), less than Passage Bio, Inc. (0), greater than Black Diamond Therapeutics, Inc. (40.26M), greater than TCR2 Therapeutics Inc. (154.27M), greater than Harpoon Therapeutics, Inc. (49.64M), less than Alector, Inc. (861.85M), less than Century Therapeutics, Inc. (477.12M), greater than Kezar Life Sciences, Inc. (121.66M), greater than Mineralys Therapeutics, Inc. (41.94M), less than NGM Biopharmaceuticals, Inc. (600.97M), greater than Revolution Medicines, Inc. (69.72M), less than Atreca, Inc. (8.93B), greater than null (-8620212.00),
Company | Enterprise Value | Market cap |
---|---|---|
481.73M | $546.22M | |
213.52M | $286.72M | |
212.96M | $147.50M | |
773.99M | $814.23M | |
0 | $38.88M | |
40.26M | $163.30M | |
154.27M | $58.11M | |
49.64M | $865.08M | |
861.85M | $488.55M | |
477.12M | $106.74M | |
121.66M | $52.61M | |
41.94M | $668.82M | |
600.97M | $128.53M | |
69.72M | $9.20B | |
8.93B | $3.57M | |
-8620212.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nkarta, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nkarta, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nkarta, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Nkarta, Inc. (NKTX)?
What is the 3-year average Enterprise Value for Nkarta, Inc. (NKTX)?
What is the 5-year average Enterprise Value for Nkarta, Inc. (NKTX)?
How does the current Enterprise Value for Nkarta, Inc. (NKTX) compare to its historical average?